News Focus
News Focus
Followers 65
Posts 27743
Boards Moderated 0
Alias Born 11/23/2016

Re: Yki post# 481008

Sunday, 01/19/2025 4:49:45 PM

Sunday, January 19, 2025 4:49:45 PM

Post# of 517474
Well essentially all of the contributors (far from all 58 are the authors) are connected to Anavex one way or another most of them as clinical trial site investigators. One in particular Stephen Macfarlane has been involved in both the AD and PD trials and been interviewed, quoted, on TV etc. in relation to Anavex and the trial. Others are or have been Scientific Advisory Board (SAB). So there is an issue of potential bias.

The EMA Raportuers and review experts won't have concern to this, as they will do their own analysis of the actual date if anything seems to raise questions. Then from that clock stop questions will be raised for Anavex to respond to.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News